|
- Dr. Chip Biotechnology Incorporation was established with a registered capital of NT$ 99 million. The main business includes developing, manufacturing and sell of nucleic acid extraction kits, polymerase chain reaction kits, rapid nucleic acid hybridization devices, biochips and other related products.
|
|
- Obtained the Small Business Innovation Research (SBIR) project from the Ministry of Economic Affairs to support the development of enterovirus identification chip and testing technology.
- Development of the world’s first enterovirus test chip that can be mass-produced.
- Development of the world’s first accelerated nucleic acid reaction equipment to increase efficiency by more than ten times.
- Obtained the Small Business Innovation Research (SBIR) project from the Ministry of Economic Affairs to support the development of rapid nucleic acid hybridization technology and devices.
|
|
- Acquired permission from the Science Park Bureau to enter the park.
- Obtained the Small Business Innovation Research (SBIR) project from the Ministry of Economic Affairs to support the development of economic animal breeding chips and genotype identification technology.
|
|
- The company factor is officially set in the Science Park.
- Initial Public Offering (IPO) of company shares.
- Obtained a subsidy from the Industrial Development Bureau for the Leading New Product Project with a polymer bio-detection chip development.
- Acquired the sales license permission from the Department of Health for the Enterovirus Identification Chip. The Enterovirus Identification Chip was honored with the 8th Innovation Research Award from the Small Business Innovation Research.
|
|
- Obtained the support of Small Business Innovation Research (SBIR) project from the Ministry of Economic Affairs with the development of respiratory atypical virus identification chip and testing technology.
|
|
- Enterovirus test chip kit was honored with the “Taiwan Excellence” award.
- Obtained the Science Park Innovation Technology Research and Development Plan to support the development of a high-throughput biological chip automatic operating system.
- Received ISO9001 certification.
- Obtained the Industry Development Industrial Technology Program from the Ministry of Economic Affairs to support the development of a microfluidic rapid hybridization chip system.
- Obtained the Innovation Technology Research and Development Program of the Science Park to support the development of a protein detection chip for influenza vaccine effectiveness.
- Acquired the permission for company OTC.
|
|
- Acquired the permission for GMP license.
- Company stocks listed on the OTC market.
- Received ISO9001 certification.
- Obtained the Innovation Technology Research and Development Program from the Science Park to support the development of genetic chips for livestock species.
- Obtained the Science Park Innovation Product Award with the product of respiratory virus in vitro diagnostic reagent kit.
- Honored the 93th Annual R&D Achievement Award of the Science Park.
|
|
- Obtained a subsidy from Science Park to develop a microfluidic nucleic acid detection biomedical chip.
|
|
- Obtained a subsidy from Science Park to develop an online bear quality detection chip.
|
|
- Obtained a subsidy from the Industrial Development Bureau of Ministry of Economic Affairs to develop a second-generation orchid virus detection chip.
|
|
- Successfully commercialized the Science Park project of dairy microbial detection chip and rapid monitoring system.
- Obtained a subsidy from the Industrial Development Bureau of Ministry of Economic Affairs to develop the Newcastle disease virus and poultry influenza virus nucleic acid chip testing reagent kit.
- Obtained a subsidy from the Innovative Technology Research and Development Program of the Science Park Bureau for the development of high-risk human papilloma virus detection chip reagents.
|
|
- Successfully commercialized the nucleic acid reagent kit of Newcastle disease virus and poultry influenza virus test chip.
- Successfully commercialized the reagents of the high-risk human papilloma virus detection chip.
|
|
- Completed the clinical trial of the human papilloma virus typing detection chip for cervical cancer.
|
|
- Acquired the registration for human papillomavirus genotyping test kit.
|
|
- Acquired the equity of iLens International Co., Ltd. and entered the contact lens industry.
|
|
- Acquired the permission for GMP license.
|
|
- The company was renamed as NeoCore Technology Co., Ltd.
|
